Hemoglobin concentration and risk of cardiovascular disease in Korean men and women - the Korean heart study

Journal of Korean Medical Science

Volumn 28, Issue 9, 2013, Pages 1316-1322

  Kim, Moo Young ^a   Jee, Sun Ha ^b   Yun, Ji Eun ^c   Baek, Soo Jin ^d   Lee, Duk Chul ^e  

^a Seoul Medical Center   (South Korea)

^b Yonsei University   (South Korea)

^c Korea National Rehabilitation Research Institute   (South Korea)

^d Health Insurance Policy Research Institute   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Cardiovascular diseases; Hemoglobins; Myocardial ischemia; Stroke

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; FACTUAL DATABASE; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOUTH KOREA; VERY ELDERLY;

CARDIOVASCULAR DISEASES; HEMOGLOBINS; MYOCARDIAL ISCHEMIA; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84884387837     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.9.1316     Document Type: Article

References (33)

1. Worlrd Health Organization. The top ten causes of death. Available at http://who.int/mediacentre/factsheets/fs310/en/index.html [accessed on 6 August 2013].
2. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291: 2616-22.
3. Mayor S. Cardiovascular disease threatens developing countries. BMJ 2004; 328: 1032.
4. Statistics Korea. Annual report on the cause of death statistics 2010. Daejeon: Statistics Korea, 2011.
5. Finch CA, Lenfant C. Oxygen transport in man. N Engl J Med 1972; 286: 407-15.
6. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Coll Cardiol 2002; 40: 27-33.
7. Kunnas T, Solakivi T, Huuskonen K, Kalela A, Renko J, Nikkari ST. Hematocrit and the risk of coronary heart disease mortality in the TAMRISK Study, a 28-year follow-up. Prev Med 2009; 49: 45-7.
8. Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, Jindal K, Mendelssohn D, Tobe S, Singer J, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis 2001; 38: 1398-407.
9. Barbui T, Finazzi G. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk. Semin Thromb Hemost 2007; 33: 321-9.
10. Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, Ma RC, Ho CS, Lam CW, Chow CC, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes Care 2006; 29: 2439-44.
11. Carter C, McGee D, Reed D, Yano K, Stemmermann G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am Heart J 1983; 105: 674-9.
12. Kim HK, Kim CH, Kim EH, Bae SJ, Choe J, Park JY, Park SW, Yun YD, Baek SJ, Mok Y, et al. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: the Korean Heart Study. Diabetes Care 2013; 36: 328-35.
13. Campbell MJ, Elwood PC, Mackean J, Waters WE. Mortality, haemoglobin level and haematocrit in women. J Chronic Dis 1985; 38: 881-9.
14. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease: the Framingham study: a 34-year follow-up. Am Heart J 1994; 127: 674-82.
15. Brown DW, Giles WH, Croft JB. Hematocrit and the risk of coronary heart disease mortality. Am Heart J 2001; 142: 657-63.
16. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, Cushman M. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005; 165: 2214-20.
17. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS). Ann Med 2012; 44: 476-86.
18. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009; 40: 3422-7.
19. Jee SH, Park JW, Lee SY, Nam BH, Ryu HG, Kim SY, Kim YN, Lee JK, Choi SM, Yun JE. Stroke risk prediction model: a risk profile from the Korean study. Atherosclerosis 2008; 197: 318-25.
20. Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 2008; 26: 871-95.
21. Smith S, Julius S, Jamerson K, Amerena J, Schork N. Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens 1994; 12: 455-62.
22. Burch GE, DePasquale NP. Hematocrit, viscosity and coronary blood flow. Dis Chest 1965; 48: 225-32.
23. Lowe GD, Forbes CD. Platelet aggregation, haematocrit, and fibrinogen. Lancet 1985; 1: 395-6.
24. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-11.
25. Bellotto F, Cati A. Anemia and myocardial ischemia: relationships and interferences. Recenti Prog Med 2006; 97: 153-64.
26. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 2002; (80): 35-8.
27. Coppola L, Guastafierro S, Sagristani M, Coppola A, Nasuti A, Ruggiero L, De Biase M, Tirelli A, Gombos G. Decreased hemoglobin levels are associated with higher plasma level of fibrinogen, irrespective of age. Am J Med Sci 2007; 333: 154-60.
28. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
29. Llauradó G, Ceperuelo-Mallafré V, Vilardell C, Simó R, Freixenet N, Vendrell J, González-Clemente JM. Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation. Diabetes Care 2012; 35: 1083-9.
30. Mattson MP. Hormesis and disease resistance: activation of cellular stress response pathways. Hum Exp Toxicol 2008; 27: 155-62.
31. Terplan M. Menstruation and cardiovascular vulnerability. Arch Intern Med 2005; 165: 120.
32. Park JK, Kim KS, Kim CB, Lee TY, Lee KS, Lee DH, Lee S, Jee SH, Suh I, Koh KW, et al. The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims. Korean J Prev Med 2000; 33: 76-82.
33. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009; 169: 515-23.